Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$145.54 - $178.83 $0 - $0
0 New
0 $0
Q3 2023

Oct 10, 2023

SELL
$167.14 - $192.77 $39,445 - $45,493
-236 Closed
0 $0
Q2 2023

Jul 21, 2023

BUY
$160.94 - $186.23 $37,981 - $43,950
236 New
236 $40,000
Q3 2022

Oct 13, 2022

BUY
$148.29 - $182.55 $24,467 - $30,120
165 New
165 $24,000
Q1 2022

Apr 26, 2022

SELL
$181.39 - $234.03 $45,166 - $58,273
-249 Closed
0 $0
Q4 2021

Jan 13, 2022

SELL
$193.69 - $247.03 $19,369 - $24,703
-100 Reduced 28.65%
249 $61,000
Q3 2021

Oct 12, 2021

BUY
$189.29 - $209.69 $18,929 - $20,969
100 Added 40.16%
349 $68,000
Q1 2021

Sep 20, 2021

BUY
$144.0 - $169.39 $35,856 - $42,178
249 New
249 $39,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Activest Wealth Management Portfolio

Follow Activest Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Activest Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Activest Wealth Management with notifications on news.